Similar Posts
Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What…
Duke Warning: Zyprexa-Diabetes Link
July 12, 2002 Duke Warning: Zyprexa-Diabetes Link FYI Since they arrived on the market in the 1990s, the so-called ‘atypicial’ antipsychotic drugs have been wrapped in controversy and promotional hype by drug companies and their paid professional spin masters who made bald claims about their “favorable side effect profile” referring…
IMR Model for Extrapolating Number of SSRI-Related Suicides
27 April 2004 Background Information Representative, U.S. The Honorable Mr. Joe Barton, United States House of Representatives. Washington DC. Representative, U.S. The Honorable Mr. James Greenwood, United States House of Representatives, Washington DC. Number of US Citizens at Risk to SSRIs This letter is to advise you that there is…
FDA Warning Letter Re: Fatal Experiment: Hexamethonium Inhalation_Johns Hopkins
FDA Warning Letter Re: Fatal Experiment: Hexamethonium Inhalation_Johns Hopkins Tue, 22 Apr 2003 An FDA Warning Letter was sent to Dr. Alkis Togias of the Johns Hopkins University Asthma & Allergy Center (March 31, 2003). The letter lists specific federal safety requirements and their violation in the hexamethonium inhalation experiment…
Evidence of Drug Harm that the FDA Sought to Suppress
Evidence of Antidepressant Harm that the FDA Sought to Suppress from FDA’s Public Advisory Committee Meeting on February 2 Evidence was presented on February 2 at AHRP’s press briefing by the following scientists: David Healy, MD, Director of the North Wales Department of Psychological Medicine and Visiting Professor, University of…
Serono to pay $704 million for Illegal Marketing AIDS drug and "voodoolike" clinical trials – NYT
Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…